26 reports

  • 7.1 BY PRODUCT CLASS
  • 7.1 BY PRODUCT CLASS

The inhibition of COX can provide relief from symptoms of inflammation and pain.

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

(France) ##.

  • Biosimilar
  • Pharmaceutical
  • United States
  • World
  • Market Shares

AES ASSOCIATED WITH THE ##MG DOSE WERE CHEST PAIN (N = ##), INFLUENZA, OUTER EAR INFECTION, AND SINUSITIS.

  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

The currently marketed branded products are either SC or IV, with the exception of Otezla, MTX, other generic systemic therapies, and add-on pain relief medicine.

  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

New data also show Cosentyx provides rapid and sustained pain relief in patients with active PsA out to ## years.

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • United States
  • Product Initiative

ACZ## provided rapid and long-lasting symptom relief by targeting interleukin-## beta, a key inflammatory mediator of the disease. "

  • Biosimilar
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Therapy
  • Pfizer Inc.
  • Indication Name

Osteoporosis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Pipeline Review, H2 2017, provides an overview of the Osteoporosis (Metabolic Disorders) pipeline landscape. Osteoporosis, or thinning bones, makes bones weak and...

  • Biosimilar
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Amgen Inc.

He added: " We are very excited at this growing partnership with Sandoz, which will enable us to prevent so many children dying without even a diagnosis and without effective pain relief.

  • Biosimilar
  • United States
  • World
  • Deals & Alliance
  • Sandoz Inc.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biosimilar
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Arthritis
  • Biosimilar
  • Therapy
  • United States
  • Pfizer Inc.
  • ULCERATIVE COLITIS - PIPELINE BY GENOR BIOPHARMA CO LTD, H1 2018

The company conducts research activities in inflammation and immunology, pain relief and fungal infection areas.

  • Autoimmune Disease
  • Biosimilar
  • United States
  • Product Initiative
  • Pfizer Inc.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biosimilar
  • Biotech
  • United States
  • Company
  • Merck & Co., Inc.

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Biosimilar
  • Chronic Disease
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • PSORIASIS - PIPELINE BY GENOR BIOPHARMA CO LTD, H2 2018

The company conducts research activities in inflammation and immunology, pain relief and fungal infection areas.

  • Biosimilar
  • Biotech
  • United States
  • Company
  • Product Initiative
  • PSORIASIS - PIPELINE BY GENOR BIOPHARMA CO LTD, H1 2018

The company conducts research activities in inflammation and immunology, pain relief and fungal infection areas.

  • Biosimilar
  • Biotech
  • United States
  • Company
  • Product Initiative

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Arthritis
  • Biosimilar
  • United States
  • Product Initiative
  • Pfizer Inc.
  • ULCERATIVE COLITIS - PIPELINE BY GENOR BIOPHARMA CO LTD, H2 2017

The company conducts research activities in inflammation and immunology, pain relief and fungal infection areas.

  • Autoimmune Disease
  • Biosimilar
  • United States
  • Product Initiative
  • Pfizer Inc.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biosimilar
  • Monoclonal Antibody
  • United States
  • Company Operations
  • Product Initiative

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biosimilar
  • Therapy
  • United States
  • Product Initiative
  • GlaxoSmithKline plc

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biosimilar
  • Biotech
  • United States
  • Company
  • Company Operations

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Biosimilar
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative

The CHMP recommendation is based on data from the pivotal Phase III ALSYMPCA (Alpharadin in Symptomatic Prostate Cancer) trial. ##-Sep-2013 Huntington Memorial Hospital announced that it is offering a newly approved therapy that prolongs life and offers much-needed pain relief for

  • Biosimilar
  • North America
  • United States
  • Company
  • Product Initiative

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biosimilar
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative